GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Valiant Laboratories VALIANTLAB.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

111.51

-3.95%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹2.37bn

FY2021FY2026

Net income

−₹32.7m

FY2021FY2026

Free cash flow

−₹472.0m

FY2021FY2026

Shareholders' equity

₹3.11bn

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue₹2.37bn₹1.39bn₹1.82bn₹3.34bn₹2.92bn₹1.82bn
Gross profit₹272.7m₹222.2m₹115.8m₹390.1m₹523.2m₹583.9m
Operating income₹26.7m₹178.3m₹72.6m₹343.1m₹400.1m₹473.9m
Net income−₹32.7m−₹22.0m₹3.2m₹290.0m₹275.0m₹305.9m
Diluted earnings per share-0.60-0.410.076.716.335.63

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assets₹4.64bn₹4.01bn₹3.43bn₹2.13bn₹1.82bn₹1.06bn
Cash and short-term investments₹331.5m₹759.9m₹1.44bn₹353.6m₹205.3m₹189.4m
Total liabilities₹1.53bn₹1.67bn₹1.06bn₹1.12bn₹1.10bn₹177.3m
Debt₹462.1m₹1.22bn₹767.1m₹602.2m₹611.3m₹6.0m
Shareholders' equity₹3.11bn₹2.34bn₹2.37bn₹1.00bn₹714.6m₹885.8m
Shares outstanding54m54m43m43m43m54m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations−₹130.0m₹13.1m₹18.9m₹560.5m₹22.5m₹91.1m
Capital spending−₹342.0m−₹1.14bn−₹458.7m−₹376.8m−₹68.8m−₹16.7m
Free cash flow−₹472.0m−₹1.13bn−₹439.8m₹183.7m−₹46.3m₹74.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹1.15bn₹919.8m₹524.6m₹462.0m₹468.2m₹554.7m₹352.3m₹214.8m
Gross profit₹420.6m₹143.6m₹35.0m₹58.7m₹71.0m₹72.5m₹65.1m₹8.9m
Operating income₹264.0m₹18.9m−₹29.4m−₹4.5m₹18.7m₹61.2m₹1.0m−₹72.6m
Net income₹211.0m₹17.6m−₹70.6m₹2.0m₹18.2m₹7.0m₹23.5m−₹47.4m
Diluted earnings per share3.890.32-1.300.040.340.130.54-1.09
Cash from operations———−₹70.0m—₹13.0m——
Capital spending———−₹190.0m—−₹1.14bn——
Free cash flow———−₹260.0m—−₹1.13bn——
Total assets—₹4.64bn—₹4.25bn—₹4.01bn—₹3.61bn
Cash and short-term investments₹331.5m₹331.5m₹629.1m₹629.1m₹759.9m₹759.9m₹1.19bn₹1.19bn
Debt—₹454.1m—₹536.1m—₹1.21bn—₹1.15bn
Shareholders' equity₹3.11bn₹3.11bn₹3.17bn₹3.17bn₹2.34bn₹2.34bn₹2.32bn₹2.32bn

Financial ratios

Data as of 21 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin11.5%16.0%6.4%11.7%17.9%32.0%
Operating margin1.1%-1.0%-5.7%11.5%14.3%26.8%
Net margin-1.4%-1.6%0.2%8.7%9.4%16.8%
Return on equity-1.1%-0.9%0.1%28.9%38.5%34.5%
Return on assets-0.7%-0.5%0.1%13.6%15.1%28.8%
Free cash flow yield2.9%15.9%8.2%16.2%1.6%—
Revenue growth71.1%-23.8%-45.5%14.5%59.9%—
Earnings growth48.5%-788.7%-98.9%5.5%-10.1%—
Current ratio1.91x3.23x7.76x2.97x3.17x5.41x
Debt to equity0.15x0.52x0.32x0.59x0.85x0.00x
Equity ratio67.0%58.5%69.1%47.2%39.3%83.3%
Interest coverage1.40x-7.63x-133.33x151.32x572.29x27.36x
Buybacks as a share of market value0.0%-25.1%-0.4%0.5%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-10.7%5.4%—
Operating income-57.3%-43.7%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin13.2%11.2%15.4%—
Operating margin5.4%7.0%10.9%—
Net margin-1.5%2.7%6.0%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023
Price to earnings-200.9-172.7—25.8
Price to sales2.82.72.62.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.